| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.273.41.26692 |
| P698 | PubMed publication ID | 9756911 |
| P2093 | author name string | L M King | |
| D H Cohn | |||
| W R Wilcox | |||
| E Délot | |||
| S G Brodie | |||
| P2860 | cites work | Characterization of human and mouse cartilage oligomeric matrix protein | Q24313275 |
| Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene | Q24337332 | ||
| Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum | Q24538707 | ||
| Genetic linkage of mild pseudoachondroplasia (PSACH) to markers in the pericentromeric region of chromosome 19 | Q28259445 | ||
| A mutation in the gene encoding the alpha 2 chain of the fibril-associated collagen IX, COL9A2, causes multiple epiphyseal dysplasia (EDM2) | Q28270822 | ||
| Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia | Q28297153 | ||
| Multiple epiphyseal dysplasia, ribbing type: a novel point mutation in the COMP gene in a South African family | Q28302994 | ||
| Regulation of collagen synthesis by ascorbic acid | Q35360129 | ||
| The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age and load | Q39462471 | ||
| A large family with features of pseudoachondroplasia and multiple epiphyseal dysplasia: exclusion of seven candidate gene loci that encode proteins of the cartilage extracellular matrix | Q41485424 | ||
| Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes | Q42456658 | ||
| Evidence for sequential appearance of cartilage matrix proteins in developing mouse limbs and in cultures of mouse mesenchymal cells | Q45072478 | ||
| Distribution and expression of cartilage oligomeric matrix protein and bone sialoprotein show marked changes during rat femoral head development | Q46294138 | ||
| The thrombospondin-like chains of cartilage oligomeric matrix protein are assembled by a five-stranded alpha-helical bundle between residues 20 and 83. | Q54637781 | ||
| Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy | Q68233831 | ||
| The biochemical defect of pseudoachondroplasia | Q70450407 | ||
| Multiple epiphyseal dysplasia, Fairbank type: morphologic and biochemical study of cartilage | Q70642317 | ||
| Cartilage oligomeric matrix protein: Isolation and characterization from human articular cartilage | Q71848784 | ||
| Tendon extracellular matrix contains pentameric thrombospondin-4 (TSP-4) | Q71940834 | ||
| Cartilage oligomeric matrix protein and thrombospondin 1. Purification from articular cartilage, electron microscopic structure, and chondrocyte binding | Q72119076 | ||
| Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint | Q72329682 | ||
| The fate of cartilage oligomeric matrix protein is determined by the cell type in the case of a novel mutation in pseudoachondroplasia | Q73919859 | ||
| P433 | issue | 41 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 26692-26697 | |
| P577 | publication date | 1998-10-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Physiological and pathological secretion of cartilage oligomeric matrix protein by cells in culture | |
| P478 | volume | 273 |
| Q42271243 | Altered synthesis of cartilage-specific proteoglycans by mutant human cartilage oligomeric matrix protein. |
| Q41770377 | An inducible cartilage oligomeric matrix protein mouse model recapitulates human pseudoachondroplasia phenotype |
| Q50322999 | Antisense Reduction of Mutant COMP Reduces Growth Plate Chondrocyte Pathology |
| Q36065648 | COMP mutation screening as an aid for the clinical diagnosis and counselling of patients with a suspected diagnosis of pseudoachondroplasia or multiple epiphyseal dysplasia |
| Q74257251 | Calreticulin, PDI, Grp94 and BiP chaperone proteins are associated with retained COMP in pseudoachondroplasia chondrocytes |
| Q52162571 | Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family. |
| Q22254372 | Cartilage oligomeric matrix protein is a calcium-binding protein, and a mutation in its type 3 repeats causes conformational changes |
| Q35149818 | Cartilage oligomeric matrix protein promotes cell attachment via two independent mechanisms involving CD47 and alphaVbeta3 integrin |
| Q24537474 | Cartilage oligomeric matrix protein-deficient mice have normal skeletal development |
| Q42597013 | Characterisation of Drosophila thrombospondin defines an early origin of pentameric thrombospondins. |
| Q40622793 | Characterization of a pseudoachondroplasia-associated mutation (His587 Arg) in the C-terminal, collagen-binding domain of cartilage oligomeric matrix protein (COMP) |
| Q41905281 | Chop (Ddit3) is essential for D469del-COMP retention and cell death in chondrocytes in an inducible transgenic mouse model of pseudoachondroplasia |
| Q77465327 | Disease-causing mutations in cartilage oligomeric matrix protein cause an unstructured Ca2+ binding domain |
| Q28190667 | Disulfide connectivity of recombinant C-terminal region of human thrombospondin 2 |
| Q52137443 | Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene. |
| Q47842070 | Effect of cartilage oligomeric matrix protein on mesenchymal chondrogenesis in vitro |
| Q33410403 | In vitro model for the analysis of synovial fibroblast-mediated degradation of intact cartilage |
| Q24313450 | Interaction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecan |
| Q44420036 | Interactions among the Three Structural Motifs of the C-Terminal Region of Human Thrombospondin-2 |
| Q30008858 | Intracellular mechanisms of molecular recognition and sorting for transport of large extracellular matrix molecules |
| Q41984401 | Mutation (D472Y) in the type 3 repeat domain of cartilage oligomeric matrix protein affects its early vesicle trafficking in endoplasmic reticulum and induces apoptosis |
| Q24290529 | Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen I, II, and IX |
| Q34085472 | Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia. |
| Q90548911 | Novel mTORC1 Mechanism Suggests Therapeutic Targets for COMPopathies |
| Q39197382 | Novel therapeutic interventions for pseudoachondroplasia |
| Q28215523 | Pseudoachondroplasia and multiple epiphyseal dysplasia: mutation review, molecular interactions, and genotype to phenotype correlations |
| Q39735942 | Pseudoachondroplasia is caused through both intra- and extracellular pathogenic pathways |
| Q33939780 | Pseudoachondroplastic dysplasia: an Iowa review from human to mouse |
| Q43787306 | Selective intracellular retention of extracellular matrix proteins and chaperones associated with pseudoachondroplasia |
| Q28508457 | Skeletal abnormalities in mice lacking extracellular matrix proteins, thrombospondin-1, thrombospondin-3, thrombospondin-5, and type IX collagen |
| Q40579869 | Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats |
| Q37444924 | The unfolded protein response and its relevance to connective tissue diseases. |
| Q35570417 | Unique matrix structure in the rough endoplasmic reticulum cisternae of pseudoachondroplasia chondrocytes |
| Q74175852 | Up-regulation of cartilage oligomeric matrix protein at the onset of articular cartilage degeneration in a transgenic mouse model of osteoarthritis |
Search more.